Aju Ib Investment Co., Ltd. has filed its 13F form on November 07, 2022 for Q3 2022 where it was disclosed a total value porftolio of $58.4 Million distributed in 7 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Arcellx, Inc. with a value of $25.9M, Rallybio Corp with a value of $10.9M, Kymera Therapeutics, Inc. with a value of $9.95M, Seer, Inc. with a value of $6.32M, and Rapt Therapeutics, Inc. with a value of $2.39M.

Examining the 13F form we can see an increase of $6.77M in the current position value, from $51.6M to 58.4M.

Aju Ib Investment Co., Ltd. is based out at Seoul, M5

Below you can find more details about Aju Ib Investment Co., Ltd. portfolio as well as his latest detailed transactions.

Portfolio value $58.4 Million
Healthcare: $58.4 Million

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 7
  • Current Value $58.4 Million
  • Prior Value $51.6 Million
  • Filing
  • Period Q3 2022
  • Filing Date November 07, 2022
  • Form Type 13F-HR
  • Activity in Q3 2022
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Aju Ib Investment Co., Ltd. Portfolio

Follow Aju Ib Investment Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aju Ib Investment Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Aju Ib Investment Co., Ltd. with notifications on news.